Ramy Mando is a Cardiology physician affiliated with Corewell Health. OpenAlex indexes 57 publications with 467 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
49050 Schoenherr Rd.
Suite 100
Shelby Twp, MI 483153848
Telephone
586-566-7870Provider last certified this registry record 29 Jul 2022.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202511 payments
- PFIZER INC.Program year20255 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.3%Beta blocker19.7%Metoprolol Succinate50%Carvedilol45%Metoprolol Tartrate4%Part D<11 patientsStatin19.5%Rosuvastatin Calcium75%Atorvastatin Calcium25%Part D≥95 patients+ 12 more classes in this area
Blood & clotting
14.2%Factor Xa inhibitor8.7%Eliquis81%Xarelto19%Part D<11 patientsP2Y12 inhibitor5.5%Clopidogrel100%Part D≥35 patientsMetabolism & gastrointestinal
2.5%SGLT2 inhibitor1.5%Jardiance100%Part D<11 patientsPotassium supplement1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Aortic Regurgitation, Time to Aortic Valve Reintervention, and Mortality in Degenerated Trifecta Versus Non-Trifecta Bioprosthesis
The American Journal of Cardiology
2024 - Mortality Outcomes in Patients With Cardiac Implantable Electronic Devices Before and After Transcatheter Aortic Valve Replacement
The American Journal of Cardiology
2023 - INTENTIONAL TAXUS BACCATA INGESTION PRESENTING WITH CARDIOGENIC SHOCK AND VENTRICULAR TACHYCARDIA
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Reda Girgis, MD
Corewell Health
Wissam Abdallah, MD
Corewell Health
Dennis Hammond, MD
Corewell Health
Jiangyong Min, MD
Corewell Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”